This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 06/25/2018
Location: Washington, DC
Subject: National Comprehensive Cancer Network Policy Summit: Policy Strategies for the "New Normal" in Healthcare to Ensure Access to High Quality Cancer Care
FDA Participant/Group: Devlin, Nina P;
Non FDA Participant/Group: Media, industry, government, and other invited participants

Event Date: 06/27/2018
Location: Silver Spring, MD
Subject: Opioid Summit with Social Media Companies
FDA Participant/Group: Several senior leaders and staff from the FDA
Non FDA Participant/Group: Industry, academia, government and other invited participants

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

Event Date: 06/26/2018
Location: Cambridge, MA
Subject: Boston Chief Medical Officers Network 2018 Presentation
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Chief Medical Officers Network

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 06/28/2018
Location: Boston, MA
Subject: Drug Information Association 2018 Global Annual Meeting
FDA Participant/Group: Marks, Peter W;
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 06/27/2018
Location: Washington, DC
Subject: Medical Device Innovation Consortium: Case for Quality Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 06/24/2018
Location: Clearwater, FL
Subject: Teratology Society 2018 Annual Meeting: Mechanisms, Models, Mothers and Babies: Bringing Birth Defects Research into Practice
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Rebecca K. Wood, J.D., Chief Counsel

No Significant Event